These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28958814)

  • 1. Avian influenza H5N1 vaccination efficacy in Egyptian backyard poultry.
    Kandeil A; Mostafa A; El-Shesheny R; El-Taweel AN; Gomaa M; Galal H; Kayali G; Ali MA
    Vaccine; 2017 Oct; 35(45):6195-6201. PubMed ID: 28958814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
    Kilany WH; Safwat M; Mohammed SM; Salim A; Fasina FO; Fasanmi OG; Shalaby AG; Dauphin G; Hassan MK; Lubroth J; Jobre YM
    PLoS One; 2016; 11(6):e0156747. PubMed ID: 27304069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.
    Connie Leung YH; Luk G; Sia SF; Wu YO; Ho CK; Chow KC; Tang SC; Guan Y; Malik Peiris JS
    Vaccine; 2013 Aug; 31(35):3536-42. PubMed ID: 23791547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate.
    Grund C; Abdelwhab el-SM; Arafa AS; Ziller M; Hassan MK; Aly MM; Hafez HM; Harder TC; Beer M
    Vaccine; 2011 Jul; 29(33):5567-73. PubMed ID: 21244859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy of H5 inactivated vaccines in meat turkey poults after challenge with Egyptian variant highly pathogenic avian influenza H5N1 virus.
    Kilany WH; Abdelwhab EM; Arafa AS; Selim A; Safwat M; Nawar AA; Erfan AM; Hassan MK; Aly MM; Hafez HM
    Vet Microbiol; 2011 May; 150(1-2):28-34. PubMed ID: 21236607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine Protection of Turkeys Against H5N1 Highly Pathogenic Avian Influenza Virus with a Recombinant Turkey Herpesvirus Expressing the Hemagglutinin Gene of Avian Influenza.
    Kapczynski DR; Dorsey K; Chrzastek K; Moraes M; Jackwood M; Hilt D; Gardin Y
    Avian Dis; 2016 Jun; 60(2):413-7. PubMed ID: 27309280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).
    Pantin-Jackwood MJ; Kapczynski DR; DeJesus E; Costa-Hurtado M; Dauphin G; Tripodi A; Dunn JR; Swayne DE
    Avian Dis; 2016 Mar; 60(1):22-32. PubMed ID: 26953940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of avian influenza H5N1 virus from vaccinated commercial layer flock in Egypt.
    El-Zoghby EF; Arafa AS; Kilany WH; Aly MM; Abdelwhab EM; Hafez HM
    Virol J; 2012 Nov; 9():294. PubMed ID: 23185975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effectiveness of rHVT-H5, inactivated H5 and rHVT-H5 with inactivated H5 prime/boost vaccination regimes in commercial broiler chickens carrying MDAs against HPAI H5N1 clade 2.2.1 virus.
    Kilany WH; Hassan MK; Safwat M; Mohammed S; Selim A; VonDobschuetz S; Dauphin G; Lubroth J; Jobre Y
    Avian Pathol; 2015 Oct; 44(5):333-41. PubMed ID: 26023824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens.
    Zeng X; Chen P; Liu L; Deng G; Li Y; Shi J; Kong H; Feng H; Bai J; Li X; Shi W; Tian G; Chen H
    Avian Dis; 2016 May; 60(1 Suppl):253-5. PubMed ID: 27309064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection conferred by recombinant turkey herpesvirus avian influenza (rHVT-H5) vaccine in the rearing period in two commercial layer chicken breeds in Egypt.
    Kilany W; Dauphin G; Selim A; Tripodi A; Samy M; Sobhy H; VonDobschuetz S; Safwat M; Saad M; Erfan A; Hassan M; Lubroth J; Jobre Y
    Avian Pathol; 2014; 43(6):514-23. PubMed ID: 25245772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avian influenza H5N1 virus infections in vaccinated commercial and backyard poultry in Egypt.
    Hafez MH; Arafa A; Abdelwhab EM; Selim A; Khoulosy SG; Hassan MK; Aly MM
    Poult Sci; 2010 Aug; 89(8):1609-13. PubMed ID: 20634514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal protection against H5N1 highly pathogenic avian influenza viruses from Vietnam in ducks vaccinated with commercial poultry vaccines.
    Cha RM; Smith D; Shepherd E; Davis CT; Donis R; Nguyen T; Nguyen HD; Do HT; Inui K; Suarez DL; Swayne DE; Pantin-Jackwood M
    Vaccine; 2013 Oct; 31(43):4953-60. PubMed ID: 23994373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and long-term protective efficacy against clade 2.3.4.4 H5N2 highly pathogenic avian influenza virus following prime-boost vaccination in turkeys.
    Santos JJS; Obadan AO; Garcia SC; Carnaccini S; Kapczynski DR; Pantin-Jackwood M; Suarez DL; Perez DR
    Vaccine; 2017 Oct; 35(42):5637-5643. PubMed ID: 28886943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Efficacy of the Inactivated H5N1 Influenza Vaccine Re-6 Against Different Clades of H5N1 Viruses Isolated in China and the Democratic People's Republic of Korea.
    Zeng X; Deng G; Liu L; Li Y; Shi J; Chen P; Feng H; Liu J; Guo X; Mao S; Yang F; Chen Z; Tian G; Chen H
    Avian Dis; 2016 May; 60(1 Suppl):238-40. PubMed ID: 27309061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
    Kapczynski DR; Esaki M; Dorsey KM; Jiang H; Jackwood M; Moraes M; Gardin Y
    Vaccine; 2015 Feb; 33(9):1197-205. PubMed ID: 25613723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of broadly reactive H5N1 vaccine against different Egyptian H5N1 viruses.
    Ibrahim M; Sultan HA; Razik AG; Kang KI; Arafa AS; Shehata AA; Saif YM; Lee CW
    Vaccine; 2015 May; 33(23):2670-7. PubMed ID: 25910922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of clade 2.3.2 H5 commercial vaccines in protecting chickens from clade 2.3.4.4 H5N8 highly pathogenic avian influenza infection.
    Yuk SS; Erdene-Ochir TO; Kwon JH; Noh JY; Hong WT; Jeong JH; Jeong S; Gwon GB; Shin JI; Sur JH; Song CS
    Vaccine; 2017 Mar; 35(9):1316-1322. PubMed ID: 28169074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Turkey Herpesvirus-AI Vaccine Virus Replication in Different Species of Waterfowl.
    Palya V; Kovács EW; Tatár-Kis T; Felföldi B; Homonnay ZG; Mató T; Sato T; Gardin Y
    Avian Dis; 2016 May; 60(1 Suppl):210-7. PubMed ID: 27309057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an effective contemporary trivalent avian influenza vaccine against circulating H5N1, H5N8, and H9N2 in Egypt.
    Gomaa MR; Khalil AA; Kandeil A; Sabir JSM; Kayed A; Moatasim Y; El Saied MF; El-Safty MM; Kayali G; Ali MA
    Poult Sci; 2019 Dec; 98(12):6289-6295. PubMed ID: 31265106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.